Net Medical Xpress Announces Major Expansion and Upgrade for Growing Hospital Market

ALBUQUERQUE, N.M., July 26, 2012 /PRNewswire/ -- New Mexico Software, Inc., d/b/a Net Medical Xpress (OTC Bulletin Board NMXC), announced today that in response to demands from the company's hospital customer base it is expanding its rapidly growing teleradiology/cardiology service into the hospital market.

Net Medical Xpress offers clinical and diagnostic programs using advanced telemedicine solutions for hospitals. The company also develops and sells FDA 510k cleared all-inclusive PACS products for the medical market.

Net Medical Xpress CEO Dick Govatski said, "In June we hired four new project account coordinators to help us expand our customer base in Texas and New Mexico. We currently have 20 hospitals out of 35 in New Mexico committed to new clinical services through Net Medical Xpress. This month we have three more customers beginning service. The service is being very well received, although it takes about four to five months to begin service due to credentialing, logistic and training issues that take time.

"Based on customer response and other reaction from the market, we are preparing to expand beyond New Mexico into Texas, Colorado, Arizona, California, Arkansas, Oklahoma and Kansas. We are currently interviewing and planning to add additional project managers to the team in order to help us expand our sales," Govatski said.

Net Medical Xpress' Specialist Program provides medical specialists to rural medical facilities on an as needed basis eliminating the need for and cost of full time staffing in infrequently needed specialties. The web-based program enables specialists located in population centers with the ability to make real-time assessments of patients at rural medical facilities through a secure and HIPAA compliant video examination, eliminating unnecessary transport that places additional financial burden and emotional strain on patients.

About Net Medical Xpress, a trade name of New Mexico Software, Inc:
Net Medical Express is a medical services company that provides clinical and diagnostic programs using advanced telemedicine solutions for rural hospitals. The company also develops FDA 510k-cleared and all-inclusive PACS products within the preventative, comprehensive, and critical healthcare segments. For more information, visit www.netmedical.com or www.nmxs.com or contact Dick Govatski, president and CEO, at 505-255-1999 or [email protected].

An investment profile on New Mexico Software may be found at http://www.hawkassociates.com/profile/nmxc.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.

For more investor-related questions contact Frank Hawkins, Hawk Associates, at 305-451-1888 or Dick Govatski at 505-255-1999 ([email protected]).

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company's Forms 10-K and 10-Q filed with the SEC.

SOURCE New Mexico Software, Inc.